The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma (Q57762250)
Jump to navigation
Jump to search
article by Tae Yong Kim et al published September 2006 in Clinical Endocrinology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma |
article by Tae Yong Kim et al published September 2006 in Clinical Endocrinology |
Statements
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma (English)
0 references
September 2006
0 references
65
0 references
3
0 references
364-368
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference